Cytokine expression and the role of Th17 cells in mice colitis

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1809-1813

  He, Ying ^a   Lin, Lian Jie ^a   Zheng, Chang Qing ^a   Jin, Yu ^a   Lin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

IBD; IFN ; IL 17; IL 6; Th1 cells; Th17 cells; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; MESSENGER RNA; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH17 CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELLS, CULTURED; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN; TH1 CELLS; TH17 CELLS; TIME FACTORS; TRINITROBENZENESULFONIC ACID;

EID: 84867774131     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ouyang Q, Tandon R, Goh KL, Ooi CJ, et al.: The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005; 21:408-413. (Pubitemid 40961165)
2. Jiang Y, Xia B, Jiang L, et al.: Association of CTLA-4gene microsatellite polymorphism with ulcerative colitis in Chinese patients. Inflamm Bowel Dis 2006; 12(5):369-373.
3. Vermeire S: Genetic susceptibility and application of genetic test in clinical management of inflammation bowel disease. Aliment Pharmacol Ther 2006; 3:2-10.
4. Weaver C T, Harrington LE, et al.: Th17: an effectorCD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24(6):677-688. (Pubitemid 43867371)
5. Harrington LE, Mangan PR, Weaver CT: Expanding the effectorCD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18(3):349-356.
6. Podolsky DK: Inflammatory bowel disease. N EngJ Med 2002; 347(6):417-429.
7. Iwakura Y, Ishigame H: The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116(5):1218-1222.
8. Park H, Li Z, Yang XO, et al.: A distinct lineage of CD4 Tcells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-1141. (Pubitemid 41541791)
9. Veldhoen M, Hocking RJ, Atkins CJ, et al.: TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189. (Pubitemid 43214587)
10. Langrish CL, Chen Y, Blumenschein WM, et al.: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201:233-240. (Pubitemid 40189432)
11. Yamada H: Th17 cells and human arthritic diseases. Nihon Rinsho Meneki Gakkai Kaishi 2010; 33(4):214-221.
12. Hue S, Ahern P, Buonocore S, et al.: Interleukin-23 drives innate and T cell-mediated intestinal inflammation. Exp Med 2006; 203:2473-2483. (Pubitemid 44664617)
13. Blaschitz C, Raffatellu M: Th17 cytokines and the gut mucosal barrier. Clin Immunol 2010; 30(2):196-203.
14. Zhang Z, Zheng M, Bindas J, et al.: Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006; 12:382-388.
15. Becker C, Dornhoff H, Neufertet C, et al.: Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. Immunol 2006; 177:2760-2764. (Pubitemid 44277789)
16. Davidson NJ, Leach MW, Fort MM, et al.: T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. Exp Med 1996; 184:241-225.
17. Fossiez F, Banchereau J, Murray R, et al.: Interleukin-17. Int Rev Immunol 1998; 16:541-551. (Pubitemid 28286184)
18. Batten M, Li J,Yi S, et al.: Interleukin-27 limits autoimmune encephalomyelitis by suppressing the development of Interleukin17 producing T cells. Nature Immunol 2006; 7(9):929-936. (Pubitemid 44263906)
19. Elson CO, Cong Y, Weaver CT, et al.: Monoclonal anti-interleukin 23 reverses active colitis in a T cell mediated model in mice. Gastroenterology 2007; 132:2359-2370. (Pubitemid 46890867)
20. Targan SR, Karp LC: Defects in mucosal immunity leading to ulcerative colifis. Immunol Rev 2005; 206:296-305. (Pubitemid 41105177)
21. Reddy KP, Markowitz JE, Ruchelli ED, et al.: Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients. Dig Dis Sci 2007; 52:365-372. (Pubitemid 46202807)
22. Hong DS, Angelo LS, Kurzrock R: Interleukin-6 and its receptor in Cancer: implications for Translational Therapeutics. Cancer 2007; 110:1911-1928. (Pubitemid 350036849)
23. Van Assche G, Magdelaine-Benzelin C, et al.: Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 2008; 134(7):1861-1868. (Pubitemid 351790744)
24. Orlando A, Mocciaro F, Civitavecchia G, et al.: Minimizing infliximab toxicity in the treatment of inflammatory bowel disease. Dig Liver Dis 2008; 40(2):236-246.